NovaBay Pharmaceuticals, Inc. - Common Stock, $0.01 par value (NBY)
CUSIP: 66987P409
Q2 2024 13F Holders as of 30 Jun 2024
- Type / Class
- Equity / Common Stock, $0.01 par value
- Shares outstanding
- 26,643,793
- Total 13F shares
- 11,501
- Share change
- +11,501
- Total reported value
- $25,420
- Price per share
- $2.24
- Number of holders
- 7
- Value change
- +$25,420
- Number of buys
- 7
Quarterly Holders Quick Answers
What is CUSIP 66987P409?
CUSIP 66987P409 identifies NBY - NovaBay Pharmaceuticals, Inc. - Common Stock, $0.01 par value in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
- Newer quarter: Q3 2024
Recent filing periods for CUSIP 66987P409:
Institutional Holders of NovaBay Pharmaceuticals, Inc. - Common Stock, $0.01 par value (NBY) as of Q2 2024
As of 30 Jun 2024,
NovaBay Pharmaceuticals, Inc. - Common Stock, $0.01 par value (NBY) was held by
7 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
11,501 shares.
The largest 7 holders included
UBS Group AG, Tower Research Capital LLC (TRC), BANK OF AMERICA CORP /DE/, NVWM, LLC, MORGAN STANLEY, Addison Advisors LLC, and NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO.
This page lists
7
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2024 vs Q3 2025 Across Filers
Q3 2025 holders
12
Q2 2024 holders
7
Holder diff
-5
| Investor | Q3 2025 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q3 2025 Value $ | Q2 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.